![]() |
市場調查報告書
商品編碼
1700029
2032 年外科密封劑和黏合劑預測:按產品類型、劑型、適應症、應用、最終用戶、地區進行的全球分析Surgical Sealants and Adhesives Market Forecasts to 2032 - Global Analysis By Product Type (Surgical Sealants, Surgical Adhesives and Other Product Types), Form, Indication, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球手術密封劑和黏合劑市場預計在 2025 年達到 36.1 億美元,預計到 2032 年將達到 81.5 億美元,預測期內的複合年成長率為 12.3%。
手術密封劑和黏合劑是用於在手術過程中黏合或密封組織的醫療物質。它可以加強組織表面之間的結合,促進癒合,減少出血並有助於傷口縫合。這些材料由天然或合成成分製成,用途廣泛,可用於重組、消化器官系統和心血管手術。黏合劑可以在組織之間建立長期連接,而密封劑通常充當阻止液體洩漏的屏障。
《英國外科雜誌》的一份報告估計,2020 年 5 月,印度每週約有 48,728 例手術被取消,導致 12 週內約有 585,000 例手術被取消。
外科手術增加
癌症和心血管疾病等需要頻繁手術的慢性疾病的盛行率上升是導致這一成長的主要原因。此外,世界人口老化也增加了需求,因為人們更容易患上需要手術治療的疾病。隨著微創手術技術的進步,密封劑和黏合劑的使用增加,以改善恢復並減少併發症。此外,新興經濟體外科治療機會的改善和醫療支出的增加也在推動市場的發展。
尖端產品高成本
複雜的配方、嚴格的品管和法規遵循要求使得這些產品的製造成本高昂,尤其是那些使用生物相容性材料和新技術的產品。這種尖端醫療設備的前期成本很高,因此通常無法廣泛普及,尤其是在預算有限的地區或規模較小的醫療保健提供者。這些考慮可能會迫使醫院和診所使用縫線和釘書釘等傳統傷口縫合技術,因為它們價格低廉。此外,高價格可能會阻礙人們使用現代、更有效率的密封劑和黏合劑,從而阻礙市場發展,尤其是在醫療資源有限的新興國家。
創傷治療產品需求不斷增加
隨著世界人口老化以及慢性病和外科手術的盛行率上升,對先進的創傷治療療法的需求也日益增加。手術密封劑和黏合劑對於加速癒合、降低感染風險和減少術後疤痕至關重要。這些產品在複雜的手術中特別有用,例如整形外科和心血管手術,因為組織密封對於癒合至關重要。此外,人們越來越關注改善患者治療效果和降低醫療成本,從而更加重視正確的傷口管理,這推動了對手術密封劑和黏合劑的需求。
複雜的應用和培訓要求
根據手術類型和所涉及的組織,這些產品通常需要精確的應用中,以確保良好的黏附、止血和組織密封。外科醫生和醫務相關人員需要接受專門培訓才能熟練這些技術,這使得實施這些技術既費時又昂貴。此外,不正確的給藥可能導致感染疾病和創傷治療不良等併發症,影響患者的預後。此外,繼續教育和技術發展的需求以及產品配方的變化限制了某些地區的市場發展,並使廣泛採用更加困難。
COVID-19 疫情對手術密封劑和黏合劑市場產生了重大影響。為了優先考慮緊急護理並節省資源,全球範圍內的選擇性手術已被推遲或取消。這導致這些產品的需求暫時下降。然而,隨著醫療保健系統的適應和手術量在關閉後恢復,市場逐漸復甦。此次疫情也凸顯了密封劑和黏合劑等先進外科解決方案在改善病患預後、減少住院時間、促進長期成長前景的重要性。
預計手術密封劑市場在預測期內將佔據最大佔有率
預計在預測期內,手術密封劑部分將佔據最大的市場佔有率。這是因為慢性病增加和人口老化導致外科手術數量的增加,從而推動了需求。此外,微創手術的進步以及有效止血和組織封閉的需求也做出了巨大貢獻。技術創新,特別是生物相容性材料和仿生密封劑,將進一步擴大應用和市場成長。此外,減少術後併發症和縮短患者康復時間的重點將推動這些產品的採用。
預計在預測期內,醫院部門的複合年成長率最高。
預計醫院部門在預測期內將出現最高的成長率。這是因為手術過程中高效可靠的止血和組織封閉至關重要。人口老化和慢性病手術數量的增加正在推動需求。由於醫院優先考慮減少術後併發症和縮短患者康復時間,因此他們擴大採用先進的密封劑。此外,醫院參與臨床試驗,並且通常是新手術技術的早期採用者,從而影響市場趨勢和產品開發。
預計亞太地區將在預測期內佔據最大的市場佔有率。這是由於人口老化迅速、慢性病盛行率上升以及外科手術數量的增加。醫療基礎設施的擴大和可支配收入的增加正在改善人們獲得先進醫療服務的機會。醫療旅遊和對微創手術的日益關注進一步刺激了需求。此外,人們對先進創傷護理和止血解決方案的認知不斷提高,推動了市場的成長。
由於微創手術的廣泛採用,預計北美在預測期內將呈現最高的複合年成長率。人口老化和慢性病的增加推動了手術需求的增加。嚴格的監管標準確保產品的高品質和創新性。強大的研發投入和技術進步,尤其是在生物相容性材料方面,將推動市場成長。報銷政策和減少住院時間的關注也導致了密封劑和黏合劑的使用增加。
According to Stratistics MRC, the Global Surgical Sealants and Adhesives Market is accounted for $3.61 billion in 2025 and is expected to reach $8.15 billion by 2032 growing at a CAGR of 12.3% during the forecast period. Surgical sealants and adhesives are medical substances used to bind or seal tissues during surgical procedures. They strengthen the link between tissue surfaces, promoting healing, reducing bleeding, and assisting in wound closure. These materials, which can be made of natural or synthetic components, are versatile and can be used in reconstructive, gastrointestinal, and cardiovascular procedures. While adhesives offer long-lasting tissue connection, sealants frequently serve as barriers to stop fluid leaks.
According to the British Journal of Surgery report, in May 2020, around 48,728 surgical procedures per week were canceled in India, estimating about 585,000 surgical procedures for 12 weeks.
Increasing surgical procedures
The rising incidence of chronic illnesses like cancer and cardiovascular conditions, which frequently call for surgical procedures, is the main cause of this increase. Furthermore, the aging of the world's population increases demand since it makes people more susceptible to illnesses that require surgery. The usage of sealants and adhesives has increased due to advancements in less invasive surgical methods, as they improve recovery and lower complications. Additionally, the market is growing as a result of enhanced access to surgical treatment and increased healthcare spending in emerging economies.
High cost of advanced products
Complex formulations, strict quality controls, and regulatory compliance requirements can make manufacturing these items costly, particularly those that use biocompatible materials or novel technology. These cutting-edge devices' high initial costs frequently prevent them from being widely available, especially in areas with tight budgets or for smaller healthcare practitioners. Due to the lower cost of traditional wound closure techniques like sutures or staples, this consideration may force hospitals and clinics to use them. Furthermore, the high price may discourage the broad use of more recent, efficient sealants and adhesives, which would hinder market expansion, especially in developing nations with limited healthcare resources.
Rising demand for wound healing products
Advanced wound healing treatments are becoming more and more necessary as the world's population ages and the prevalence of chronic illnesses and surgical procedures rises. Surgical adhesives and sealants are essential for encouraging quicker healing, lowering the risk of infection, and decreasing post-operative scarring. These products are particularly helpful in complicated surgeries where tissue sealing is essential for healing, like orthopedic and cardiovascular treatments. Additionally, there is a greater focus on proper wound management as a result of the growing emphasis on improving patient outcomes and lowering healthcare costs, which is driving up demand for surgical sealants and adhesives.
Complex application and training requirements
Depending on the type of surgery and tissue involved, these products frequently require precise application procedures to guarantee good adhesion, hemostasis, and tissue sealing. Adoption takes longer and costs more since surgeons and medical personnel need specific training to become proficient in these techniques. Furthermore, incorrect administration might affect patient outcomes by causing complications like infections or insufficient wound healing. Their widespread usage is made more difficult by the requirement for ongoing education and skill development as well as the variation in product compositions, which restricts market expansion in particular areas.
The COVID-19 pandemic significantly impacted the surgical sealants and adhesives market, as elective surgeries were postponed or canceled globally to prioritize emergency care and conserve resources. This led to a temporary decline in demand for these products. However, the market witnessed a gradual recovery as healthcare systems adapted and surgical volumes rebounded post-lockdowns. The pandemic also highlighted the importance of advanced surgical solutions, including sealants and adhesives, in improving patient outcomes and reducing hospital stays, driving long-term growth prospects.
The surgical sealants segment is expected to be the largest during the forecast period
The surgical sealants segment is expected to account for the largest market share during the forecast period, due to the increasing volume of surgical procedures, driven by a rise in chronic diseases and an aging population, fuels demand. Additionally, advancements in minimally invasive surgeries and the need for effective hemostasis and tissue sealing contribute significantly. Technological innovations, particularly in biocompatible materials and biomimetic sealants, further expand applications and market growth. Furthermore, the focus on reducing post-surgical complications and improving patient recovery times enhances the adoption of these products.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their need for efficient, reliable hemostasis and tissue sealing during surgeries is paramount. Increased surgical volumes due to aging populations and chronic diseases drive demand. Hospitals prioritize minimizing post-operative complications and reducing patient recovery times, leading to greater adoption of advanced sealants. Furthermore, hospitals often participate in clinical trials and are early adopters of new surgical technologies, influencing market trends and product development.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rapidly growing aging population and rising prevalence of chronic diseases, increasing surgical procedure volumes. Expanding healthcare infrastructure and rising disposable incomes improve access to advanced medical treatments. Medical tourism and a growing focus on minimally invasive surgeries further accelerate demand. Additionally, increasing awareness about advanced wound care and hemostasis solutions boosts market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to high adoption rates of minimally invasive surgeries. An aging population and rising chronic disease prevalence increase surgical demand. Stringent regulatory standards ensure high-quality, innovative products. Strong R&D investments and technological advancements, particularly in biocompatible materials, propel market growth. Reimbursement policies and a focus on reducing hospital stays also contribute to increased sealant and adhesive usage.
Key players in the market
Some of the key players in Surgical Sealants and Adhesives Market include 3M, Johnson & Johnson, Baxter International, CryoLife, Integra LifeSciences Corporation, Medtronic, Sealantis Ltd., Molnlycke Health Care, Globus Medical, Smith & Nephew, Tissuemed, Vermillion Inc., Asahi Kasei Corporation, TCL Surgical, Stryker Corporation, and Braun Melsungen AG.
In February 2025, Johnson & Johnson MedTech, an emerging leader in neurovascular care, announced today the launch of the CEREGLIDE(TM) 92 Catheter System, a next-generation .092" catheter with the INNERGLIDE(TM) 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system.
In December 2024, 3M and US Conec Ltd. announced a strategic licensing agreement for 3M(TM) Expanded Beam Optical Interconnect technology, a solution to meet the performance and scalability needs of next-generation data centers and advanced network architectures. The collaboration combines advanced optical technology from 3M with US Conec's expertise in high-density connectivity systems, expanded beam optics, and precision manufacturing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.